Lars Gedda

2.3k total citations
85 papers, 1.9k citations indexed

About

Lars Gedda is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Lars Gedda has authored 85 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Radiology, Nuclear Medicine and Imaging, 37 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Lars Gedda's work include Radiopharmaceutical Chemistry and Applications (36 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and HER2/EGFR in Cancer Research (20 papers). Lars Gedda is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (36 papers), Monoclonal and Polyclonal Antibodies Research (24 papers) and HER2/EGFR in Cancer Research (20 papers). Lars Gedda collaborates with scholars based in Sweden, Germany and United States. Lars Gedda's co-authors include Jörgen Carlsson, Katarina Edwards, Karl Andersson, Vladimir Tolmachev, Stefan Sjöberg, Hanna Björkelund, Erika Bohl Kullberg, Anna Orlova, Fredrik Y. Frejd and Hans Lundqvist and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

In The Last Decade

Lars Gedda

84 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Gedda Sweden 28 1.1k 719 506 292 195 85 1.9k
Arutselvan Natarajan United States 28 934 0.9× 677 0.9× 820 1.6× 145 0.5× 406 2.1× 80 2.5k
Giulio Fracasso Italy 30 395 0.4× 749 1.0× 435 0.9× 312 1.1× 395 2.0× 81 2.3k
Zhide Guo China 26 664 0.6× 735 1.0× 787 1.6× 600 2.1× 398 2.0× 99 2.8k
Tae Sup Lee South Korea 24 453 0.4× 842 1.2× 346 0.7× 316 1.1× 304 1.6× 81 2.0k
Kathlynn C. Brown United States 29 627 0.6× 1.4k 1.9× 371 0.7× 231 0.8× 397 2.0× 58 2.6k
Susanne Kossatz Germany 24 397 0.4× 617 0.9× 760 1.5× 114 0.4× 301 1.5× 63 1.8k
François Hindré France 26 297 0.3× 584 0.8× 203 0.4× 267 0.9× 719 3.7× 49 1.8k
Jessica P. Houston United States 18 362 0.3× 413 0.6× 210 0.4× 201 0.7× 82 0.4× 50 1.5k
Richard Tavaré United States 25 799 0.8× 313 0.4× 763 1.5× 104 0.4× 211 1.1× 35 1.7k
Celeste A.S. Regino United States 25 547 0.5× 818 1.1× 295 0.6× 738 2.5× 431 2.2× 34 2.3k

Countries citing papers authored by Lars Gedda

Since Specialization
Citations

This map shows the geographic impact of Lars Gedda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Gedda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Gedda more than expected).

Fields of papers citing papers by Lars Gedda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Gedda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Gedda. The network helps show where Lars Gedda may publish in the future.

Co-authorship network of co-authors of Lars Gedda

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Gedda. A scholar is included among the top collaborators of Lars Gedda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Gedda. Lars Gedda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gedda, Lars, et al.. (2024). Novel thermosensitive small multilamellar lipid nanoparticles with promising release characteristics made by dual centrifugation. European Journal of Pharmaceutical Sciences. 206. 106999–106999. 3 indexed citations
2.
Gedda, Lars, et al.. (2023). Spontaneous Formation of Ultrasmall Unilamellar Vesicles in Mixtures of an Amphiphilic Drug and a Phospholipid. Langmuir. 39(32). 11337–11344. 7 indexed citations
3.
Gedda, Lars, et al.. (2020). Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomes. Journal of Colloid and Interface Science. 578. 281–289. 16 indexed citations
4.
Edwards, Katarina, et al.. (2019). Osmoprotective effect of ubiquinone in lipid vesicles modelling the E. coli plasma membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1861(7). 1388–1396. 11 indexed citations
5.
Gedda, Lars, Hanna Björkelund, Anna Asplund, et al.. (2013). Evaluation of Real-Time Immunohistochemistry and Interaction Map as an Alternative Objective Assessment of HER2 Expression in Human Breast Cancer Tissue. Applied immunohistochemistry & molecular morphology. 21(6). 497–505. 2 indexed citations
6.
Gedda, Lars, et al.. (2012). Experimental Radionuclide Therapy of HER2-Expressing Xenografts Using Two-Step Targeting Nuclisome Particles. Journal of Nuclear Medicine. 53(3). 480–487. 8 indexed citations
7.
Friedman, Mikaela, Sara Lindström, Helene Andersson Svahn, et al.. (2009). Engineering and characterization of a bispecific HER2 × EGFR‐binding affibody molecule. Biotechnology and Applied Biochemistry. 54(2). 121–131. 55 indexed citations
8.
Leuchowius, Karl‐Johan, Irene Weibrecht, Ulf Landegren, Lars Gedda, & Ola Söderberg. (2009). Flow cytometric in situ proximity ligation analyses of protein interactions and post‐translational modification of the epidermal growth factor receptor family. Cytometry Part A. 75A(10). 833–839. 48 indexed citations
9.
Persson, Mikael, et al.. (2007). In Vitro Evaluation of Two Polyhedral Boron Anion Derivatives as Linkers for Attachment of Radioiodine to the Anti-HER2 Monoclonal Antibody Trastuzumab. Cancer Biotherapy and Radiopharmaceuticals. 22(5). 585–596. 3 indexed citations
10.
Tolmachev, Vladimir, Fredrik Nilsson, Charles Widström, et al.. (2006). 111In-benzyl-DTPA-ZHER2:342, an affibody-based conjugate for in vivo imaging of HER2 expression in malignant tumors.. PubMed. 47(5). 846–53. 85 indexed citations
11.
Tolmachev, Vladimir, Anna Orlova, Qichun Wei, et al.. (2004). Comparative Biodistribution of Potential Anti- Glioblastoma Conjugates [ 111 In]DTPA-hEGF and [ 111 In]Bz-DTPA-hEGF in Normal Mice. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 491–502. 20 indexed citations
12.
Gedda, Lars, Anna Orlova, Alexander Bruskin, et al.. (2004). [ 177 Lu]Bz-DTPA-EGF: Preclinical Characterization of a Potential Radionuclide Targeting Agent Against Glioma. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 195–204. 15 indexed citations
13.
Tolmachev, Vladimir, Anna Orlova, Qichun Wei, et al.. (2004). Comparative Biodistribution of Potential Anti-Glioblastoma Conjugates [<SUP>111</SUP>In]DTPA-hEGF and [<SUP>111</SUP>In]Bz-DTPA-hEGF in Normal Mice. Cancer Biotherapy and Radiopharmaceuticals. 19(4). 491–501. 12 indexed citations
14.
Kullberg, Erika Bohl, Jörgen Carlsson, Katarina Edwards, et al.. (2003). Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy. International Journal of Oncology. 23(2). 461–7. 20 indexed citations
15.
Orlova, Anna, Alexander Bruskin, Lars Gedda, et al.. (2003). [ 111 In]Bz-DTPA-hEGF: Preparation and In Vitro Characterization of a Potential Anti-Glioblastoma Targeting Agent. Cancer Biotherapy and Radiopharmaceuticals. 18(4). 643–654. 15 indexed citations
16.
Persson, Mikael, Anna Orlova, Lars Gedda, Jörgen Carlsson, & Vladimir Tolmachev. (2002). Cellular processing of iodinated and astatinated trastuzumab in cultured SK-BR-3 breast cancer cells. Cancer Biotherapy and Radiopharmaceuticals. 17. 353–354. 1 indexed citations
17.
Gedda, Lars, Göran Hesselager, Rolf Larsson, et al.. (2002). A New Antibody Recognizing the vIII Mutation of Human Epidermal Growth Factor Receptor. Tumor Biology. 23(2). 61–69. 31 indexed citations
18.
Orlova, Anna, Mark Lubberink, O. Lebeda, et al.. (2002). Comparative Biodistribution of the Radiohalogenated (Br, I and At) Antibody A33. Implications for In Vivo Dosimetry.. Cancer Biotherapy and Radiopharmaceuticals. 17(4). 385–396. 15 indexed citations
19.
Nilsson, Per, Lars Gedda, Anna Sjöström, Qinghai Zhao, & Jörgen Carlsson. (1997). Penetration and Binding of EGF-Dextran Conjugates in Cultured-Cell Spheroids. European Journal of Cell Biology. 74. 118–118. 1 indexed citations
20.
Tolmachev, Vladimir, Hans Lundqvist, Igor B. Sivaev, et al.. (1997). Labelling of boron containing compounds with halogen isotopes. Journal of Labelled Compounds and Radiopharmaceuticals. 40. 122. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arutselvan Natarajan Breakdown of academic impact, for papers by Giulio Fracasso Breakdown of academic impact, for papers by Zhide Guo Breakdown of academic impact, for papers by Tae Sup Lee Breakdown of academic impact, for papers by Kathlynn C. Brown Breakdown of academic impact, for papers by Susanne Kossatz Breakdown of academic impact, for papers by François Hindré Breakdown of academic impact, for papers by Jessica P. Houston Breakdown of academic impact, for papers by Richard Tavaré Breakdown of academic impact, for papers by Celeste A.S. Regino
Rankless by CCL
2026